Beclomethasone dipropionate in Crohn's ileitis: A randomised, double-blind trial

These results demonstrate that beclomethasone dipropionate significantly reduces the relapse rate in post-active Crohn's ileitis patients compared with placebo after induction of remission with a short course of systemic steroids, and is well tolerated.